| | | | | | | | | Sponsored | | Respiratory season starts long before samples arrive. As testing volumes increase, a reliable quality control strategy becomes even more important. Now is the time to review your QC approach and prepare with third-party molecular respiratory controls designed to help monitor assay performance, support confidence in results, and keep your laboratory ready for the season ahead. |
|
|
| | |
| |
| | |
|
|
| | | | | | The University of Michigan, Ann Arbor has released the results of its most recent Monitoring the Future (MTF) Longitudinal Panel Study. The National Institutes of Health (NIH) shared key findings in a press release. |
|
|
| | Renew Biotechnologies has published a new study in Frontiers in Neurology, providing insights into neurodegeneration and where it takes place in the brain. Details of the study are reported in a press release. |
|
|
Sponsored | | Explore the future of hemostasis with Stago as we discuss innovation, evolving laboratory challenges, digital transformation, and our continued commitment to partnering with laboratories worldwide to advance patient care. |
|
|
|
| |
| | |
|
|
| | | | | | Sponsored | | Roche Lab Automation now connects to an ever-expanding ecosystem of Roche and certified third-party instruments. Curate your ideal test menu and workflow from a broad list of industry partners, delivering more flexibility. |
|
|
| | |
| |
| | |
|
|
| | | | | | Enabled by the recent U.S. Food and Drug Administration (FDA) 510(k) clearance of ELISIO-HX, NIPRO CORPORATION, through its U.S.-based subsidiary Nipro Medical Corporation, has announced the U.S. commercial launch of the medium-cutoff dialyzer featuring super high-flux membrane technology. |
|
|
|
| |
| | |
|
|
| | | | | | Discover how next-generation handheld diagnostics are changing medicine at the speed of care in our recent e-book. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|